The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier

J Periodontol. 2000 Mar;71(3):418-24. doi: 10.1902/jop.2000.71.3.418.

Abstract

Background: In order to achieve optimal effects, growth factors including platelet-derived growth factor (PDGF) should be delivered with a biodegradable carrier that will release therapeutic concentrations over a sufficient length of time. The purpose of this study was to evaluate the bone regenerative effect of PDGF-BB delivered with a chitosan/tricalcium phosphate (TCP) sponge carrier in a rat calvarial defect model.

Methods: The PDGF-BB-loaded chitosan/TCP sponge carrier was fabricated by freeze-drying a mixture of chitosan solution and TCP powder and soaking in a PDGF-BB solution. The release kinetics of PDGF-BB loaded onto the sponge were measured in vitro with 125I-labeled PDGF-BB. Chitosan/TCP sponges with and without PDGF-BB were implanted into 8 mm calvarial defects in rats. Rats were sacrificed at 2 and 4 weeks following implantation, and histologic and histomorphometrical examinations were performed.

Results: In vitro evaluation demonstrated that an effective therapeutic concentration of PDGF-BB following a high initial burst release was maintained throughout the examination period. In the histologic examination, the chitosan/TCP sponge carrier promoted osseous healing of the rat calvarial defects as compared to controls. The addition of PDGF-BB to the carrier further enhanced bone regeneration. Evidence of the degraded sponge matrix was observed mingled within the newly formed bone without connective tissue encapsulation.

Conclusions: The results of this study support the use of chitosan/TCP sponges as a delivery system for growth factors and demonstrate that PDGF-BB loaded onto chitosan/TCP sponge carriers has an osteogenic effect on bone regeneration in vivo.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants
  • Animals
  • Becaplermin
  • Biocompatible Materials*
  • Biopolymers*
  • Bone Diseases / drug therapy
  • Bone Diseases / pathology
  • Bone Regeneration / drug effects*
  • Bone Substitutes*
  • Calcium Phosphates*
  • Chitin / analogs & derivatives*
  • Chitosan
  • Delayed-Action Preparations
  • Drug Carriers
  • Drug Delivery Systems
  • Iodine Radioisotopes
  • Male
  • Osteogenesis / drug effects
  • Platelet-Derived Growth Factor / administration & dosage
  • Platelet-Derived Growth Factor / therapeutic use*
  • Proto-Oncogene Proteins c-sis
  • Radiopharmaceuticals
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins
  • Skull / drug effects
  • Skull / pathology
  • Wound Healing

Substances

  • Biocompatible Materials
  • Biopolymers
  • Bone Substitutes
  • Calcium Phosphates
  • Delayed-Action Preparations
  • Drug Carriers
  • Iodine Radioisotopes
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Radiopharmaceuticals
  • Recombinant Proteins
  • alpha-tricalcium phosphate
  • tetracalcium phosphate
  • Chitin
  • Becaplermin
  • calcium phosphate, monobasic, anhydrous
  • Chitosan
  • calcium phosphate
  • calcium phosphate, dibasic, anhydrous